Logo

American Heart Association

  1
  0


Final ID: WP222

External Validation of an Automated Hemorrhage Detection and Segmentation Algorithm on Follow-up CT scans in the AcT trial

Abstract Body: Background and Aims:
Machine learning models have shown promising potential for automated hemorrhage detection and segmentation, alleviating highly time-consuming manual contouring and facilitating rapid clinical diagnosis. External validation is essential to assess model generalizability and performance across new dataset configurations. To this end, we externally validated a novel model for hemorrhage detection and segmentation in an unseen randomized-controlled trial dataset.
Methods: A novel segmentation architecture based on denoising diffusion probabilistic models was utilized for segmenting hemorrhage. The model had been trained upon a set of 331 CT scans with manually segmented parenchymal hemorrhage lesions. External validation was conducted using the AcT (Alteplase compared to Tenecteplase) trial in which patients underwent post-thrombolysis follow-up CT scans. Ground truth regarding hemorrhage presence was determined by expert readers blinded to the algorithm’s results who performed manual contouring and graded hemorrhages using the Heidelberg classification. Model performance was then evaluated through using diagnostic performance measures and the Dice coefficient.
Results: Among the 1338 patients with follow-up CT scans, two types of hemorrhages were adjudicated: (a) any kind of hemorrhage (230/1338) and (b) remote or local hemorrhages classified as PH1 or worse (170/1338). The algorithm achieved sensitivity of 89.4% (95% CI 84.8-94.1%) for hemorrhages ≥PH1 and 61.7% (95% CI 55.5-68.0%) for any kind of hemorrhage where specificity of 92.8% (95% CI 91.3-94.3%), positive predictive value of 64.0% (95% CI 57.6-70.3%), negative predictive value of 92.1% (95% CI 90.5-93.7%) and accuracy of 87.4% was achieved. Dice was 0.582 (95% CI 0.538, 0.629) for any kind of hemorrhage and 0.611 (0.555, 0.667) for hemorrhages ≥PH1.
Conclusions: Our automated model for hemorrhage segmentation demonstrated robust performance in this external clinical trial dataset, achieving high sensitivity for large hemorrhages and high specificity for smaller hemorrhages. Future work will seek to further optimize the algorithm’s performance for detection and segmentation of smaller hemorrhages.
  • Zhang, Jianhai  ( UNIVERSITY OF CALGARY , Calgary , Alberta , Canada )
  • Kaveeta, Chitapa  ( UNIVERSITY OF CALGARY , Calgary , Alberta , Canada )
  • Alhabli, Ibrahim  ( UNIVERSITY OF CALGARY , Calgary , Alberta , Canada )
  • Bala, Fouzi  ( University of Calgary , Calgary , Alberta , Canada )
  • Almekhlafi, Mohammed  ( University of Calgary , Calgary , Alberta , Canada )
  • Menon, Bijoy  ( University of Calgary , Calgary , Alberta , Canada )
  • Qiu, Wu  ( University of Calgary , Calgary , Alberta , Canada )
  • Singh, Nishita  ( Foothills Medical Centre , Calgary , Alberta , Canada )
  • Ganesh, Aravind  ( UNIVERSITY OF CALGARY , Calgary , Alberta , Canada )
  • Author Disclosures:
    Jianhai Zhang: DO NOT have relevant financial relationships | Chitapa Kaveeta: No Answer | Ibrahim Alhabli: DO NOT have relevant financial relationships | Fouzi Bala: DO NOT have relevant financial relationships | Mohammed Almekhlafi: DO NOT have relevant financial relationships | Bijoy Menon: DO have relevant financial relationships ; Individual Stocks/Stock Options:Circle CVI:Active (exists now) ; Advisor:Boehringer Ingelheim:Past (completed) | Wu Qiu: No Answer | Nishita Singh: DO NOT have relevant financial relationships | Aravind Ganesh: DO have relevant financial relationships ; Ownership Interest:SnapDx Inc:Active (exists now) ; Research Funding (PI or named investigator):Philips Foundation:Past (completed) ; Research Funding (PI or named investigator):Microvention:Past (completed) ; Speaker:Biogen:Past (completed) ; Speaker:Alexion:Past (completed) ; Consultant:Servier Canada:Past (completed) ; Ownership Interest:Let's Get Proof (Collavidence Inc):Active (exists now)
Meeting Info:
Session Info:

Intracerebral Hemorrhage Posters I

Wednesday, 02/05/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity

Swanson Kyle, Wu Joseph, Mukherjee Souhrid, Walther Parker, Lai Celine, Yan Christopher, Shivnaraine Rabindra, Leitz Jeremy, Pang Paul, Zou James

A Systematic Approach to Prompting Large Language Models for Automated Feature Extraction from Cardiovascular Imaging Reports

Goldfinger Shir, Mackay Emily, Chan Trevor, Eswar Vikram, Grasfield Rachel, Yan Vivian, Barreto David, Pouch Alison

More abstracts from these authors:
Development and testing of a fully automated tool for the detection, segmentation, and characterization of cervical carotid atherosclerotic disease

Zhang Jianhai, Qiu Wu, Ganesh Aravind, Barakhanov Kazbek, Kaveeta Chitapa, Alhabli Ibrahim, Pensato Umberto, Ramkumar Raksha, Macdonald M Ethan, Singh Nishita, Menon Bijoy

Association between ipsilateral stroke and non-stenotic (<50%) carotid disease – Analysis from the Alteplase compared to Tenecteplase Trial

Ignacio Katrina, Tkach Aleksander, Sajobi Tolulope, Buck Brian, Menon Bijoy, Almekhlafi Mohammed, Ganesh Aravind, Singh Nishita, Nagendra Shashank, Bala Fouzi, Alhabli Ibrahim, Baguley Elizabeth, Poulin Therese, Sjonnesen Kirsten, Swartz Richard, Catanese Luciana

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)